Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2011 / Cilt: 21 - Sayı: 3

A case of Gittelman's Syndrome

Gittelman sendromlu olgu

Pages
143–145
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We reported a 26 year ol d female treated for these symptoms for 10 years and diagnosed as Gittelman's Syndrome and cured by magnesium.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gittelman's syndrome (GS), also called Gittelman's variant of Bartter's syndrome, is an autosomal recessive renal disorder characterized by hypokalemia, hypomagnesemia, metabolic alka losis, and hypocalciuria.
📊
Key Findings & Data:GS is caused by inactivating mutations in the thiazide-sensitive Na/Cl co-transporter gene .The most common symptoms are weakness, muscle weakness and cramps, tetany, fatigue, noct uria and polydipsia.
💡
Conclusion & Impact:We reported a 26 year ol d female treated for these symptoms for 10 years and diagnosed as Gittelman's Syndrome and cured by magnesium.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Gittelman's syndrome (GS), also called Gittelman's variant of Bartter's syndrome, is an autosomal recessive renal disorder characterized by hypokalemia, hypomagnesemia, metabolic alka losis, and hypocalciuria. GS is caused by inactivating mutations in the thiazide-sensitive Na/Cl co-transporter gene .The most common symptoms are weakness, muscle weakness and cramps, tetany, fatigue, noct uria and polydipsia. We reported a 26 year ol d female treated for these symptoms for 10 years and diagnosed as Gittelman's Syndrome and cured by magnesium.

Özet

Gittelman Sendromu (GS) otozomal resesif kalıtımlı, hipokalemik alkaloz, hipomagnezemi ve hipokalsiüri ile karakterize Bartter sendromunun (BS) varyantı olarak değerlendirilen renal tubuler bir hastalıktır. Gittelman sendromu tiyazid duyarlı Na/Cl ko-transporter genini etkisizleştiren mutasyon ile oluşur. Yaygın semptomları halsizlik, kas güçsüzlüğü ve kramplar, tetani, yorgunluk, nokturi ve polidipsidir. Burada 10 yıldır benzer yakınmalarla çeşitli defalar başvurduğu poliklinik muayenelerinde semptomatik tedavi verilen ve Gittelman Sendromu tanısı konan magnezyum ile tedavi edilen bir olguyu sunduk.

🔖

Cite This Article

ALFATLI, U., ATİLA, D., BARIŞIK, V., BIÇAK, F. (2011). A case of Gittelman's Syndrome. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 21 - Sayı: 3, 143–145. https://ajindex.com/articles/268443

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kurtz, I. Molecular pathogenesis of Bartter's and Gitelman's syndromes. Kidney Int 1998;54: 1396-410 2. Simon, DB, Lifton RP. Ion transporter mutations in Gitelman's and Bartter's syndromes. Curr Opin Nephrol Hypertens 1998:7: 43-7. 3. Amin J. Barakat,Owen M. Rennert. Gitelman's Syndrome (Familial Hypokalemia-hypomagnesemia): J Nephrol 2001; 14: 43-7 4. Kleta R, Basoglu C, Kuwertz-Broking E. New treatment options for Bartter's syndrome. N Engl J Med 2000; 343:661 5. Sabath E, Meade P. Pathophysiology of functional mutations of the thiazide-sensitive Na-Cl cotransporter in Gitelman disease Am J Physiol Renal Physiol 2004:287: F195-F203. 6. Schepkens H, Lameire N. Gitelman’s syndrome: an overlooked cause of chronic hypokalemia and hypomagnesemia in adults. Acta Clin Belg 2001; 56: 248-54